Modified Release Amino Acid Formulation for PKU Metabolic Control

Solution Overview

Problem

Individuals with phenylketonuria (PKU) face challenges with lifelong ingestion of synthetic, fast-absorbed free amino acid formulas, leading to unmet medical needs such as severe mental retardation, muscle loss, and metabolic imbalances due to rapid amino acid absorption and high dietary acid load.

Innovation Solution

A modified release amino acid formulation that mimics the digestion of natural proteins, prolonging the release of amino acids to improve nitrogen balance, reduce muscle catabolism, and stabilize glucose and insulin levels, thereby addressing elevated amino acid concentrations and fluctuations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If fast-absorbed free amino acid formulas are used, then amino acid availability is improved, but rapid absorption causes high peak concentrations and increased dietary acid load

Engineering Contradiction:
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent applies dynamics by making the amino acid release rate adjustable and time-dependent. The modified release formulation dynamically controls amino acid release to mimic natural protein digestion kinetics, preventing rapid absorption while ensuring adequate availability over time. This resolves the contradiction by transforming static fast-release formulas into dynamic systems that adapt release rates to physiological needs.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent changes the release rate parameter of amino acids from fast to modified release. By altering this key parameter, the formulation achieves both adequate amino acid availability and avoidance of harmful peak concentrations. The modified release profile adjusts the temporal distribution of amino acid release to match natural protein digestion, thereby resolving the contradiction between availability and harmful effects.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If synthetic free amino acid mixtures are used, then protein needs are met, but nitrogen balance deteriorates and muscle catabolism increases

Engineering Contradiction:
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent uses dynamics to match amino acid release patterns with physiological protein synthesis demands. By making release rates time-dependent and mimicking natural protein digestion, the formulation improves nitrogen retention and reduces muscle catabolism while still meeting protein needs. This dynamic approach resolves the contradiction between fulfilling protein requirements and maintaining nitrogen balance.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The modified release formulation acts as an intermediary between synthetic amino acid mixtures and natural proteins. It combines the controllability of synthetic formulations with the beneficial absorption characteristics of natural proteins, thereby improving nitrogen balance and reducing muscle catabolism while meeting protein needs.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Object-affected harmful factors

If natural proteins are restricted, then phenylalanine levels are controlled, but amino acid absorption becomes unbalanced

Engineering Contradiction:
Core Design Contradiction:
Object-affected harmful factorsVSStability of the object's composition

Solution Approach 1:

The patent changes the release rate parameter of amino acids in the formulation to mimic natural protein digestion kinetics. This parameter change ensures balanced amino acid absorption while maintaining phenylalanine level control through the low-phenylalanine diet. The modified release profile compensates for the restrictions imposed by natural protein limitation.

Inventive Principle:
Principle #35Parameter changes

4Quantity of substance

If high doses of free amino acids are administered, then amino acid concentrations increase, but dietary acid load increases

Engineering Contradiction:
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent applies periodic action by distributing amino acid release over an extended time period rather than delivering high doses all at once. The modified release formulation creates multiple smaller peaks of amino acid availability that mimic natural meal patterns, thereby achieving adequate amino acid concentrations while reducing the instantaneous dietary acid load.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS20230321021A1Methods of normalizing amino acid metabolism
Publication Date: 2023.10.12
  • US20230321021A1 patent drawing
  • US20230321021A1 patent drawing
  • US20230321021A1 patent drawing

AI summary

Methods of normalizing amino acid metabolism in subjects on restricted protein diets and supplemental amino acids, using specially formulated amino acids that mimic the absorption and metabolism of naturally occurring proteins, are described.